Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 5:33 pm Sale | 13G | MIRATI THERAPEUTICS INC MRTX | PERCEPTIVE ADVISORS LLC | 3,283,783 5.9% | -409,733 (-11.09%) | View |
2022-02-11 10:01 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | Avoro Capital Advisors LLC | 5,075,000 9.2% | 540,000 (+11.91%) | View |
2022-02-10 08:27 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | VANGUARD GROUP INC | 4,438,977 8.04% | 406,739 (+10.09%) | View |
2022-02-09 09:22 am Sale | 13G | MIRATI THERAPEUTICS INC MRTX | FMR LLC | 2,735,803 4.954% | -42,554 (-1.53%) | View |
2022-02-04 09:21 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | WELLINGTON MANAGEMENT GROUP LLP | 3,145,632 5.7% | 3,145,632 (New Position) | View |
2022-01-10 12:54 pm Sale | 13G | MIRATI THERAPEUTICS INC MRTX | BlackRock Inc. BLK | 2,756,675 4.99% | -1,523,737 (-35.60%) | View |
2021-02-16 3:30 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | PERCEPTIVE ADVISORS LLC | 3,693,516 7.4% | 490,110 (+15.30%) | View |
2021-02-12 08:00 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | Avoro Capital Advisors LLC | 4,535,000 9.02% | 621,565 (+15.88%) | View |
2021-02-10 11:28 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | VANGUARD GROUP INC | 4,032,238 7.92% | 964,627 (+31.45%) | View |
2021-02-08 10:27 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | FMR LLC | 2,778,357 5.457% | 762,537 (+37.83%) | View |
2021-01-29 5:23 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | BlackRock Inc. BLK | 4,280,412 8.5% | 1,523,713 (+55.27%) | View |
2020-10-30 9:44 pm Purchase | 13D | MIRATI THERAPEUTICS INC MRTX | Boxer Capital LLC | 10,290,847 18.9% | 1,522,564 (+17.36%) | View |
2020-02-14 4:46 pm Purchase | 13D | MIRATI THERAPEUTICS INC MRTX | Boxer Capital LLC | 8,768,283 18.7% | 1,170,000 (+15.40%) | View |
2020-02-14 4:12 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | PERCEPTIVE ADVISORS LLC | 3,203,406 8.1% | 1,374,200 (+75.13%) | View |
2020-02-14 4:02 pm Sale | 13G | MIRATI THERAPEUTICS INC MRTX | Cormorant Asset Management LP | 1,782,392 4.15% | -367,608 (-17.10%) | View |
2020-02-14 10:00 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | Avoro Capital Advisors LLC | 3,913,435 9.91% | 100,200 (+2.63%) | View |
2020-02-11 4:39 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | VANGUARD GROUP INC | 3,067,611 7.77% | 3,067,611 (New Position) | View |
2020-02-07 11:24 am Sale | 13G | MIRATI THERAPEUTICS INC MRTX | FMR LLC | 2,015,820 5.111% | -743,061 (-26.93%) | View |
2020-02-05 12:15 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | BlackRock Inc. BLK | 2,756,699 7% | 703,750 (+34.28%) | View |
2019-11-14 4:04 pm Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | Cormorant Asset Management LP | 2,150,000 5.45% | 398,301 (+22.74%) | View |